This brand name is authorized in Nigeria.
The drug CO-MEPIRYL contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
786Z46389E - METFORMIN HYDROCHLORIDE
|
|
Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. |
|
2
|
UNII
6KY687524K - GLIMEPIRIDE
|
|
Glimepiride is an orally active hypoglycaemic substance belonging to the sulphonylurea group. It may be used in non-insulin dependent (type 2) diabetes mellitus. Glimepiride acts mainly by stimulating insulin release from pancreatic beta cells. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-2825 | Tablet | Co-Mepiryl Tablet 2 mg/500 mg Tablet TAB 500 mg; 2 mg 3 x 10's (in blisters) | Tablet for oral administration. A bilayer capsule-shaped tablets, light yellow colour with “MBN” on one-layer, white colour and No engraving on the other layer | 31/07/2024 |
| B4-6590 | Tablet | Co-Mepiryl Forte Tablet TAB 1000 mg; 2 mg 3 x 10's (in blisters) | Tablet for oral administration. A bilayer capsule-shaped tablets, light yellow colour with “MBN” on one-layer, white colour and no engraving on the other layer | 31/07/2024 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-2825, B4-6590 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.